Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

R&D tax credits among anticipated changes for US healthcare

February 24, 2009 Research and Development US, healthcare

With the election of Barack Obama, widespread changes are anticipated for US healthcare and ultimately for the pharmaceutical industry. Although …
News

Bringing global trials teams together

February 23, 2009 Research and Development clinical trials, global

The world is getting bigger and smaller at the same time. When the internet began to really catch on about …
Feature

Raptiva suspended in Europe over safety concerns

February 20, 2009 Research and Development, Sales and Marketing Europe, Rapitva

Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …
News

Servier claims victory over NICE in osteoporosis

February 19, 2009 Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …
News

GSK’s diabetes candidate enters phase III

February 19, 2009 Research and Development GSK, diabetes

A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …
News

Genzyme says new plant approval is imminent

February 18, 2009 Research and Development, Sales and Marketing Genzyme

Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …
News

Lilly to boost biotech stake in NeuroSearch deal

February 17, 2009 Research and Development Denmark, Europe, NeuroSearch

Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …
News

Pharma needs fresh ideas from outside industry, says Barker

February 17, 2009 Research and Development, Sales and Marketing ABPI, strategy

Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …
News

GSK: renewing the HIV pipeline

February 16, 2009 Research and Development GSK, HIV

GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …
News

Bayer’s cardiovascular drug enters phase III

February 13, 2009 Research and Development, Sales and Marketing Bayer, cv

Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …
News

Publish and be damned?

February 10, 2009 Research and Development clinical trials, publication

Feature

Schering-Plough invests in Scotland drug discovery centre

February 6, 2009 Research and Development Merck, Scotland

Schering-Plough is to invest around $30 million in its early drug discovery work in Scotland. The company is investing a …
News

What are pharma’s core competencies?

February 5, 2009 Research and Development, Sales and Marketing pharma, strategy

Pharma has always been a highly profitable industry, and has historically been among the best performing industrial sectors in terms …
Feature

The Pharmafocus Interview: David Gillen

February 3, 2009 Research and Development Pfizer, UK, medicines access

David Gillen says he is a born optimist. But Pfizer UK’s medical director says this positive outlook doesn’t blind him …
Feature

Evidence HRT could reduce bowel cancer risk

February 2, 2009 Research and Development, Sales and Marketing HRT

A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025